Inferra AI / Company / NGVT

Ingevity Corp

NGVT · Materials

Last earnings Jul 29, 2026

Key results

EPSquarter

$1.39

earnings per share of $1.39 was up 38% Adjusted EBITDA of $110.0 million increased 9% and adjusted EBITDA margin improved to 30.1% primarily due to the successful execution of repositioning actions in Performance Chemicals

SEC original ↗Ingevity Corp — Earnings release (8-K exhibit)EX-99Aug 4, 2025

Net revenuequarter

$365.1 million

Net sales of $365.1 million declined 7% primarily due to lower sales in the Performance Chemicals segment.

SEC original ↗Ingevity Corp — Earnings release (8-K exhibit)EX-99Aug 4, 2025

Adjusted earnings increased 39% to $51.1 million and diluted adjusted earnings per share (EPS) increased 38% to $1.39.

SEC original ↗Ingevity Corp — Earnings release (8-K exhibit)EX-99Aug 4, 2025

Free cash flowquarter

$79.0 million

Liquidity Other Operating cash flow was $79.0 million with free cash flow of $66.8 million, reflecting improved profitability, lower repositioning spend in Performance Chemicals and disciplined capital spend.

SEC original ↗Ingevity Corp — Earnings release (8-K exhibit)EX-99Aug 4, 2025

AI analysis

Q2 2025 · reported Aug 4, 2025

Based on: Earnings release + parent 8-K + 10-Q — transcript not held

Net revenue · Q2 2025
$365.1M
EX-99 · Aug 4, 2025
EPS · Q2 2025
$1.39
EX-99 · Aug 4, 2025
Free cash flow · Q2 2025
$79.0M
EX-99 · Aug 4, 2025

The quarter in charts

Guidance ladder — revenue

Delivered vs the company's guided range

EX-99 · Aug 4, 2025 Guide as stated by the company; range and midpoint computed from the stated figure.

Headline figures

MetricQ2 2025Prior qtrYear ago
EPS$1.39——
Net revenue$365.1 million——
Free cash flow$79.0 million——

EX-99 · Aug 4, 2025

Guidance · company-stated

Direction: Raised

Revenue$390 million

“Full Year 2025 Guidance Due to solid first half results and improved North America auto production forecasts, the Company is raising the low-end of adjusted EBITDA guidance with updated guidance of between $390 million and $415 million and maintaining sales guidance between $1.25 billion and $1.40 billion.”

Midpoint vs latest-quarter revenue+6.8%computed from stated figures

Classified from the release's primary full-year outlook statement.

Next earningsNo verified date on fileNo date is estimated or imported

Cash flow & capex

Free cash flow$79.0M

Capital allocation

There were no share repurchases for the quarter and $353.4 million remains available under the current $500 million Board authorization.

We have excluded the following items from segment EBITDA interest expense associated with corporate debt facilities, interest income, income taxes, depreciation, amortization, restructuring and other income (charges), net, inventory lower of cost or market charges associated with restructuring actions, goodwill impairment charges, acquisition and other-related income (costs), litigation verdict charges, gain (loss) on strategic investments, loss on CTO resales, CTO supply contract termination charges, proxy contest charges, and pension and postretirement settlement and curtailment income (charges), net.

What changed vs last quarter

  • Guide midpoint vs latest-quarter revenue +6.8% computed from stated figures
General educational research only — not investment advice.Every figure is as stated in the held documents; values marked “computed from stated figures” are arithmetic on those stated figures. Guidance shown is the company’s own stated guidance. No price targets, no recommendations, no consensus estimates.

Event summary

Refer to the section entitled Use of non-GAAP financial measures within this release

Based on: Earnings release + parent 8-K + 10-Q — transcript not held

Guidance & outlook

Direction: Raised

Revenue: “Full Year 2025 Guidance Due to solid first half results and improved North America auto production forecasts, the Company is raising the low-end of adjusted EBITDA guidance with updated guidance of between $390 million and $415 million and maintaining sales guidance between $1.25 billion and $1.40 billion.”

Revenue — Raised (“raising”)
“Full Year 2025 Guidance Due to solid first half results and improved North America auto production forecasts, the Company is raising the low-end of adjusted EBITDA guidance with updated guidance of between $390 million and $415 million and maintaining sales guidance between $1.25 billion and $1.40 billion.”

Classified from the release's primary full-year outlook statement.

Capital allocation

There were no share repurchases for the quarter and $353.4 million remains available under the current $500 million Board authorization.

SEC original ↗Ingevity Corp — Earnings release (8-K exhibit)EX-99Aug 4, 2025

We have excluded the following items from segment EBITDA interest expense associated with corporate debt facilities, interest income, income taxes, depreciation, amortization, restructuring and other income (charges), net, inventory lower of cost or market charges associated with restructuring actions, goodwill impairment charges, acquisition and other-related income (costs), litigation verdict charges, gain (loss) on strategic investments, loss on CTO resales, CTO supply contract termination charges, proxy contest charges, and pension and postretirement settlement and curtailment income (charges), net.

SEC original ↗Ingevity Corp — Earnings release (8-K exhibit)EX-99Aug 4, 2025

Ingevity uses the following non-GAAP measures Adjusted earnings (loss) is defined as net income (loss) plus restructuring and other (income) charges, net, goodwill impairment charges, acquisition and other-related (income) costs, pension and postretirement settlement and curtailment (income) charges, loss on CTO resales, CTO supply contract termination charges, (gain) loss on strategic investments, debt refinancing fees, litigation verdict charges, proxy contest charges, and the income tax expense (benefit) on those items, less the provision (benefit) from certain discrete tax items.

SEC original ↗Ingevity Corp — Earnings release (8-K exhibit)EX-99Aug 4, 2025

Free Cash Flow is defined as the sum of net cash provided by (used in) the following items operating activities less capital expenditures.

SEC original ↗Ingevity Corp — Earnings release (8-K exhibit)EX-99Aug 4, 2025

Net Debt is defined as the sum of notes payable, short-term debt, current maturities of long-term debt and long-term debt including finance lease obligations less the sum of cash and cash equivalents, restricted cash associated with our new market tax credit financing arrangement, and restricted investment associated with certain finance lease obligations, excluding the allowance for credit losses on held-to-maturity debt securities held within the restricted investment.

SEC original ↗Ingevity Corp — Earnings release (8-K exhibit)EX-99Aug 4, 2025

Net Debt Ratio is defined as Net Debt divided by the last twelve months Adjusted EBITDA, inclusive of acquisition-related pro forma adjustments.

SEC original ↗Ingevity Corp — Earnings release (8-K exhibit)EX-99Aug 4, 2025

Strategy & priorities

We are also advancing our portfolio evaluation with a focus on retaining and investing in businesses that leverage our core competencies and also allow us to continue driving sustainable growth and delivering best-in-class EBITDA margins.

SEC original ↗Ingevity Corp — Earnings release (8-K exhibit)EX-99Aug 4, 2025

We have excluded the following items from segment EBITDA interest expense associated with corporate debt facilities, interest income, income taxes, depreciation, amortization, restructuring and other income (charges), net, inventory lower of cost or market charges associated with restructuring actions, goodwill impairment charges, acquisition and other-related income (costs), litigation verdict charges, gain (loss) on strategic investments, loss on CTO resales, CTO supply contract termination charges, proxy contest charges, and pension and postretirement settlement and curtailment income (charges), net.

SEC original ↗Ingevity Corp — Earnings release (8-K exhibit)EX-99Aug 4, 2025

Three Months Ended June 30, Six Months Ended June 30, In millions 2025 2024 2025 2024 Performance Materials $ $ (0.1) $ $ (0.1) Performance Chemicals 4.8 Advanced Polymer Technologies 2.5 2.5 (Gain) loss on strategic investments $ 2.5 $ (0.1) $ 2.5 $ 4.7 (9) Charges represent legal and other professional service fees as well as incremental proxy solicitation costs related to a proxy contest.

SEC original ↗Ingevity Corp — Earnings release (8-K exhibit)EX-99Aug 4, 2025

Ingevity uses the following non-GAAP measures Adjusted earnings (loss) is defined as net income (loss) plus restructuring and other (income) charges, net, goodwill impairment charges, acquisition and other-related (income) costs, pension and postretirement settlement and curtailment (income) charges, loss on CTO resales, CTO supply contract termination charges, (gain) loss on strategic investments, debt refinancing fees, litigation verdict charges, proxy contest charges, and the income tax expense (benefit) on those items, less the provision (benefit) from certain discrete tax items.

SEC original ↗Ingevity Corp — Earnings release (8-K exhibit)EX-99Aug 4, 2025

Adjusted EBITDA is defined as net income (loss) plus interest expense, net, provision (benefit) for income taxes, depreciation, amortization, restructuring and other (income) charges, net, goodwill impairment charges, acquisition and other-related (income) costs, litigation verdict charges, (gain) loss on strategic investments, loss on CTO resales, CTO supply contract termination charges, proxy contest charges, and pension and postretirement settlement and curtailment (income) charges, net.

SEC original ↗Ingevity Corp — Earnings release (8-K exhibit)EX-99Aug 4, 2025

Risks & headwinds

This impairment was recorded as a result of an impact assessment of heightened global trade uncertainty due to tariff announcements during the quarter, which prompted reevaluation of prior assumptions regarding the pace and strength of industrial demand recovery in key markets.

SEC original ↗Ingevity Corp — Earnings release (8-K exhibit)EX-99Aug 4, 2025

Performance Materials Performance Materials sales were down 2% to $153.9 million as higher sales in North America partially offset lower sales in Asia and Europe, attributable primarily to tariff uncertainty.

SEC original ↗Ingevity Corp — Earnings release (8-K exhibit)EX-99Aug 4, 2025

Advanced Polymer Technologies Sales in Advanced Polymer Technologies were down $4.6 million, or 10%, to $43.3 million primarily as a result of softening customer demand, which intensified late in the quarter due to indirect impacts from tariffs, particularly in Europe.

SEC original ↗Ingevity Corp — Earnings release (8-K exhibit)EX-99Aug 4, 2025

Segment EBITDA decreased from $9.8 million to $0.9 million largely due to the planned extended outage in Q2 to install new boilers noted last quarter, and lower volumes attributed to slow industrial demand and tariff-related pressures.

SEC original ↗Ingevity Corp — Earnings release (8-K exhibit)EX-99Aug 4, 2025

We have excluded the following items from segment EBITDA interest expense associated with corporate debt facilities, interest income, income taxes, depreciation, amortization, restructuring and other income (charges), net, inventory lower of cost or market charges associated with restructuring actions, goodwill impairment charges, acquisition and other-related income (costs), litigation verdict charges, gain (loss) on strategic investments, loss on CTO resales, CTO supply contract termination charges, proxy contest charges, and pension and postretirement settlement and curtailment income (charges), net.

SEC original ↗Ingevity Corp — Earnings release (8-K exhibit)EX-99Aug 4, 2025

Ingevity uses the following non-GAAP measures Adjusted earnings (loss) is defined as net income (loss) plus restructuring and other (income) charges, net, goodwill impairment charges, acquisition and other-related (income) costs, pension and postretirement settlement and curtailment (income) charges, loss on CTO resales, CTO supply contract termination charges, (gain) loss on strategic investments, debt refinancing fees, litigation verdict charges, proxy contest charges, and the income tax expense (benefit) on those items, less the provision (benefit) from certain discrete tax items.

SEC original ↗Ingevity Corp — Earnings release (8-K exhibit)EX-99Aug 4, 2025

Competitors

Competitors & peers

Same GICS sector — classification peers, not declared competitors

Documents

Filings

30 documents

Earnings releases

10 documents

Presentations

0 documents

No presentations for Ingevity Corp are held in this edition of the library.

Transcripts

0 documents

No transcripts for Ingevity Corp are held in this edition of the library.

See also the earnings calendar for every tracked company’s next earnings date.